Signal transduction pathways Flashcards
endocrine
cell to blood to target cell
paracrine
cell to target cell
autocrine
cell to same cell
contact dependant
cell to cell by membrane attached proteins
requires direct contact
signal transduction
requires amplification of the signal within the cell to trigger the response
will require a system to slow/stop the amplification
faults here can lead to cancer
signal transduction pathways
4 types of mechanism:
- direct ligand gated channel
- G-protein-coupled
- tyrosine kinase-linked
- nuclear receptor super family
ligand gated channel
ion binds to receptor causing conformational change allowing influx into the cell through the channel
include:
uniporter
symporter
antiporter
ATPase dependant transport
also includes diffusion, facilitated transport and energy dependant transport
drug resistance ATPase
drug enters cell via diffusion, cell activates ATPase transport to remove drug from cell
G-protein-coupled
binding causes conformational shape change
can now bind to G-a subunit
triggers further change, causing dissociation of intracellular Go proteins which bind to, and cause a change to other transporter molecules
target of ~40% modern drugs
cAMP signal pathway:
messenger binds to receptor in the cellular membrane
causes change in the G-protein bound to the receptor
one sub-unit of the G-protein bins to adenylyl cyclase in the membrane
ATP arrives and is converted into cAMP
vasopressin
causes antidiuresis
single amino acid mutations in V2R can cause this ability to regulate water to be lost
tyrosine kinase-linked - Boron pg.111
includes several cytokines: IL-2,3,4,5,6 and more
there is a poir of receptors that hetero/homo-dimerise
GTP donates phosphate to activate intermediaries triggering a response
deficits in phosphatase will result in the ability to stop response signal being lost, since phosphate cannot be cleaved
homodimer - e.g. HER1 + HER1
very stable
heterodimer - e.g. HER1 + HER2
more unstable
hypoxia induced factors - von hippel lindau function
causes angiogenesis and proliferation
protective in the case of injury
e.g. diabetic retinopathy where process is disrupted
hypoxia induced factors - von hippel lindau function
causes angiogenesis and proliferation
protective in the case of injury
e.g. diabetic retinopathy where process is disrupted
VEGF - vascular endothelial growth factor
inhibited by thalidomide
? therapeutic use in haematological conditions
e.g. malignancy, retinopathy
VEGF - vascular endothelial growth factor
inhibited by thalidomide
? therapeutic use in haematological conditions
e.g. malignancy, retinopathy